Skip to main content
Anti-dandruff Active

Octopirox

Octopirox is one of the most efficient anti-dandruff actives available on the market today. Designed specifically to treat seborrheic dermatitis and dry scalp, piroctone olamine offers additional benefits: it is environmentally friendly, multifunctional (doubles as preserving agent), and can be used in various cosmetic formats.
Benefits

Scalp Care Benefits

  • Dandruff-and flake-free
  • Itch-free
  • Gentle on scalp

 

Additional Benefits 

  • Low aquatic toxicity (no labeling required)
  • Broad-spectrum preservation
Product details
Chemical Name
  • Piroctone Olamine
Product Function
  • Antidandruff Agents
Chemical Type
  • Heterocyclic Compounds
Applications
  • Shampoo
  • Hair Conditioner
  • Hair Styling
  • Antiperspirant & Deodorant
Performance Claims
  • Anti-dandruff
  • Scalp Care
  • Enables clear formulations
  • Broad Spectrum Preservation
Technical Data
  • Appearance: White to faintly yellowish-white crystalline powder
  • Active Substance (ca.): min 99%
  • INCI-Name: Piroctone olamine
Applications

Anti-dandruff/anti-itch: Shampoo, conditioner, scalp tonic, cream rinse

Deodorants: Roll-on, spray, foot deodorant cream, stick

Anti-acne products: Gel, lotion, cleanser

Formulation Features
  • Transparent formulation
  • Easy to formulate
  • pH- and temperature stable

Download File

Octopirox

Please choose one of the available product configurations:
No files are available for this product.

Login Required

Log in or register to ClariHub for our full set of ingredient documentation, formulations and more resources!
Log in or register to ClariHub for our full set of ingredient documentation, formulations and more resources!
{{title}}
{{description}}
{{title}}
{{description}}
{{title}}
{{description}}
{{title}}
{{description}}
We could not find any related items.
{{localizedTemplateName}}
{{title}}
{{description}}
{{localizedTemplateName}}
{{title}}
{{description}}
{{localizedTemplateName}}
{{title}}
{{description}}
{{localizedTemplateName}}
{{title}}
{{description}}
We could not find any related items.

Page summary

Summarization in progress